Skip to content
DataLookout
Start free
Menu

PURENCT06840106

Nasal Steam Therapy for Post-extubation Respiratory Events

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 8 words Show 5 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Dec 31, 2027 to May 12, 2025
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 1, 2025 to Feb 18, 2025
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Wisconsin upper respiratory symptom survey-24, WURSS-24
Timeframe: From enrollment to the end of treatment at Day 8, and follow up visit at Day 15

Secondary (2)

Incidence and severity of cough
Thyroid cancer-Quality of Life (ThyCa-QoL)

Arms and interventions

Nasal Steam therapy strategyExperimental

Nasal steam therapy is performed once a every other day for a total of 3three times. The steam inhalation stimulates the acupoints of bilateral LI20, EX-HN8, and EX-HN9

Routine management strategyActive comparator

This study is a practical clinical study, and the selection of drugs and other treatment methods will be based on the doctor's clinical judgment regarding the patient's symptoms, degree of improvement, etc. Drug administration or patient education will be implemented according to symptoms. Depending on the patient's symptoms and degree of improvement, the clinician may utilize all drugs currently used in clinical practice to improve upper respiratory symptoms, if necessary. All drugs that fall under the Anatomical Therapeutic Chemical Classification System (ATC) codes of non-disease treatment (R01), throat disease treatment (R02), lung disease or expectorant (R03, R05), and other respiratory organ drugs (R06, R07) and other drugs that clinicians orally administer in current clinical practice for the purpose of improving upper respiratory symptoms will be collected.

Procedures: Nasal steam therapy, Routine management strategy

Sites

1 site in 1 country

  • Ilsan Cha HospitalGoyang-si, Gyeonggi-do, South Korea